Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 736 AL 750

Development, validity, and reliability of the General Activities of Daily Living Scale: a multidimensional measure of activities of daily living for older people

Paula JJ, Bertola L, Ávila RT, Assis Lde O, Albuquerque M, Bicalho MA, Moraes EN, Nicolato R, Malloy-Diniz LF.

Braz J Psychiatry. 2014 Apr-Jun;36(2):143-52. doi: 10.1590/1516-4446-2012-1003. Epub 2014 Feb 4.

Emergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimer's prevention

Koscik RL, La Rue A, Jonaitis EM, Okonkwo OC, Johnson SC, Bendlin BB, Hermann BP, Sager MA.

Dement Geriatr Cogn Disord. 2014;38(1-2):16-30. doi: 10.1159/000355682. Epub 2014 Feb 20.

ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?

Kanekiyo T, Xu H, Bu G.

Neuron. 2014 Feb 19;81(4):740-54. doi: 10.1016/j.neuron.2014.01.045.

Functional brain connectivity using fMRI in aging and Alzheimer's disease

Dennis EL, Thompson PM.

Neuropsychol Rev. 2014 Mar;24(1):49-62. doi: 10.1007/s11065-014-9249-6. Epub 2014 Feb 23.

New applications of disease genetics and pharmacogenetics to drug development

Roses AD, Saunders AM, Lutz MW, Zhang N, Hariri AR, Asin KE, Crenshaw DG, Budur K, Burns DK, Brannan SK.

Curr Opin Pharmacol. 2014 Feb;14:81-9. doi: 10.1016/j.coph.2013.12.002. Epub 2014 Jan 3.

Cognitive subdomain responses to galantamine in Alzheimer's disease

Song J, Ahn IS, Kang HS, Myung W, Lee Y, Woo SY, Ku HM, Hwang TY, Carroll BJ, Kim DK.

J Nerv Ment Dis. 2014 Mar;202(3):253-9. doi: 10.1097/NMD.0000000000000107.

Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview

Brosseron F, Krauthausen M, Kummer M, Heneka MT.

Mol Neurobiol. 2014 Oct;50(2):534-44. doi: 10.1007/s12035-014-8657-1. Epub 2014 Feb 25.

Advances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer's disease based on multi-modal MRI techniques

Hu Z, Wu L, Jia J, Han Y.

Neurosci Bull. 2014 Apr;30(2):198-206. doi: 10.1007/s12264-013-1407-y. Epub 2014 Feb 27.

Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysis

Teipel SJ, Grothe MJ, Filippi M, Fellgiebel A, Dyrba M, Frisoni GB, Meindl T, Bokde AL, Hampel H, Klöppel S, Hauenstein K; EDSD study group.

J Alzheimers Dis. 2014;41(1):69-83. doi: 10.3233/JAD-131829.

Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study

Spalletta G, Caltagirone C, Padovani A, Sorbi S, Attar M, Colombo D, Cravello L; E V O L U T I O N study Working Group.

PLoS One. 2014 Feb 19;9(2):e89216. doi: 10.1371/journal.pone.0089216. eCollection 2014.

Cerebral blood flow reduction associated with orientation for time in amnesic mild cognitive impairment and Alzheimer disease patients

Yamashita KI, Taniwaki Y, Utsunomiya H, Taniwaki T.

J Neuroimaging. 2014 Nov-Dec;24(6):590-594. doi: 10.1111/jon.12096. Epub 2014 Mar 5.

Amyloid imaging in depression: a predictor of Alzheimer's disease?

Camacho V, Lleó A.

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):711-3. doi: 10.1007/s00259-014-2741-7.

Pittsburgh compound B retention and progression of cognitive status--a meta-analysis

Chen X, Li M, Wang S, Zhu H, Xiong Y, Liu X.

Eur J Neurol. 2014 Aug;21(8):1060-1067. doi: 10.1111/ene.12398. Epub 2014 Feb 24.

The Chinese version of story recall: a useful screening tool for mild cognitive impairment and Alzheimer's disease in the elderly

Shi J, Wei M, Tian J, Snowden J, Zhang X, Ni J, Li T, Jian W, Ma C, Tong Y, Liu J, Liu T, Wang P, Wang Y.

BMC Psychiatry. 2014 Mar 10;14:71. doi: 10.1186/1471-244X-14-71.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias